Dexterous Endoscopes awarded CHF 130k EPFL Ignition and Innogrant funding
Dexterous Endoscopes secured CHF 130k in EPFL Startup Launchpad funding, combining the Ignition and Innogrant programs. The support will expand the team, advance a clinically viable prototype, and enable the first cadaver trials.
Dexterous Endoscopes has received two competitive funding instruments from EPFL Startup Launchpad: an Ignition Grant of CHF 30,000 and an Innogrant of CHF 100,000.
The Ignition Grant helps early-stage EPFL spin-offs validate their concepts, while the Innogrant provides seed funding to accelerate the transition of promising research into startups with market potential.
This funding will be used to grow the team with complementary medical device expertise, advance towards a minimally clinically viable product, and conduct the first preclinical cadaver trials to validate the clinical hypotheses behind our variable stiffness endoscopes.
These steps mark important progress toward making ENT surgeries faster, less invasive, and safer for patients.
More news
Pitching at Swissnex Startup Camp in San Francisco
Dexterous Endoscopes was one of 10 Swiss startups selected for the Innosuisse Startup Camp at Swissnex in San Francisco, pitching its variable stiffness endoscope to the Bay Area innovation community.
Dexterous Endoscopes named Top100 Swiss Startup Newcomer of the Year 2026
Dexterous Endoscopes won the Newcomer of the Year award, recognising the best newcomer in the Top100 Swiss Startup ranking 2026, at the award night in Zurich.
FIT supports Dexterous Endoscopes with a CHF 100k Tech Seed loan
The Foundation for Innovation and Technology (FIT) has granted Dexterous Endoscopes a CHF 100,000 Tech Seed loan to continue preclinical trials and prepare the regulatory and industrialisation stages of its variable stiffness endoscope.
Our new home: Biopôle, supported by the Biopôle Starting Fund
Dexterous Endoscopes has opened its office at Biopôle in Lausanne and has been awarded CHF 63,000 from the Biopôle Starting Fund.
